Get the Stockscreener App
2.30
2.54%
-0.06
After Hours:
2.32
0.02
+0.87%
Prokidney Corp stock is traded at $2.30, with a volume of 1.25M.
It is down -2.54% in the last 24 hours and down -18.44% over the past month.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
See More
Previous Close:
$2.36
Open:
$2.37
24h Volume:
1.25M
Relative Volume:
0.10
Market Cap:
$310.49M
Revenue:
-
Net Income/Loss:
$-35.47M
P/E Ratio:
-4.0351
EPS:
-0.57
Net Cash Flow:
$-124.27M
1W Performance:
-3.36%
1M Performance:
-18.44%
6M Performance:
+86.99%
1Y Performance:
-4.17%
1-Day Range:
$2.27
$2.43
1-Week Range:
$2.27
$2.56
52-Week Range:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Name
Prokidney Corp
Sector
Industry
Phone
336-999-7028
Address
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Compare PROK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.30 | 318.58M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-24 | Initiated | JP Morgan | Neutral |
| Sep-10-24 | Initiated | Guggenheim | Buy |
| Mar-07-24 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-23 | Initiated | BTIG Research | Buy |
| Dec-21-22 | Initiated | Jefferies | Buy |
| Nov-10-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-18-22 | Initiated | UBS | Buy |
| Oct-14-22 | Initiated | Citigroup | Buy |
| Sep-23-22 | Initiated | BofA Securities | Buy |
| Sep-02-22 | Initiated | Evercore ISI | Outperform |
View All
Prokidney Corp Stock (PROK) Latest News
Will ProKidney Corp. bounce back from current support2025 Volatility Report & Weekly Top Gainers Trade List - Newser
ProKidney Corp. stock volume spike explained2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
Can ProKidney Corp. reach resistance levels soonJuly 2025 Highlights & Low Risk Profit Maximizing Plans - خودرو بانک
Key metrics from ProKidney Corp.’s quarterly data2025 Institutional Moves & Free Daily Entry Point Trade Alerts - Newser
Candlestick signals on ProKidney Corp. stock todayQuarterly Trade Summary & Long-Term Capital Growth Strategies - Newser
Using data filters to optimize entry into ProKidney Corp.Weekly Investment Report & Weekly Stock Performance Updates - Newser
Using RSI to spot recovery in ProKidney Corp.Earnings Risk Summary & Precise Entry and Exit Recommendations - Newser
What is the PEG ratio of ProKidney Corp.July 2025 Opening Moves & Safe Entry Trade Reports - خودرو بانک
How moving averages guide ProKidney Corp. tradingWeekly Loss Report & Low Drawdown Investment Ideas - Newser
Multi factor analysis applied to ProKidney Corp.Weekly Investment Report & Growth Focused Stock Reports - Newser
Will ProKidney Corp. benefit from green energy policiesMarket Risk Analysis & Fast Exit and Entry Trade Guides - خودرو بانک
What analysts say about ProKidney Corp. stock2025 Technical Overview & Low Risk Profit Maximizing Plans - خودرو بانک
ProKidney Corp. stock chart pattern explained2025 Valuation Update & Long Hold Capital Preservation Tips - Newser
Will ProKidney Corp. stock recover after recent dropChart Signals & Momentum Based Trading Ideas - Newser
Will ProKidney Corp. stock recover after earningsJuly 2025 Closing Moves & Technical Buy Zone Confirmations - خودرو بانک
What are ProKidney Corp.’s recent SEC filings showingEarnings Performance Report & Capital Efficiency Focused Strategies - خودرو بانک
Is ProKidney Corp. a good ESG investmentWeekly Profit Recap & Fast Moving Trade Plans - خودرو بانک
ProKidney Corp. Enters Reversal Setup in Weekly Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Will ProKidney Corp. price bounce be sustainableJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Price action breakdown for ProKidney Corp.July 2025 Patterns & Technical Entry and Exit Alerts - Newser
Is ProKidney Corp. meeting your algorithmic filter criteriaBuy Signal & Momentum Based Trading Ideas - Newser
ProKidney (PROK.O) Dives 5.6%: A Technical and Order-Flow Deep Dive - AInvest
What moving averages say about ProKidney Corp.Weekly Trade Analysis & Fast Gaining Stock Reports - Newser
Has ProKidney Corp. found a price floorJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Volume spikes in ProKidney Corp. stock – what they meanPortfolio Value Summary & Weekly Market Pulse Updates - Newser
Analyzing drawdowns of ProKidney Corp. with statistical toolsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Does ProKidney Corp. qualify in momentum factor screeningWeekly Loss Report & Reliable Trade Execution Plans - Newser
Using R and stats models for ProKidney Corp. forecastingQuarterly Earnings Summary & Reliable Intraday Trade Alerts - Newser
ProKidney Corp. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - thegnnews.com
Regression analysis insights on ProKidney Corp. performance2025 Biggest Moves & Weekly Watchlist for Hot Stocks - Newser
Should value investors consider ProKidney Corp.Take Profit & Free Weekly Watchlist of Top Performers - beatles.ru
Prokidney Corp Stock (PROK) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):